Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells.

Wrzesinski C, Paulos CM, Kaiser A, Muranski P, Palmer DC, Gattinoni L, Yu Z, Rosenberg SA, Restifo NP.

J Immunother. 2010 Jan;33(1):1-7. doi: 10.1097/CJI.0b013e3181b88ffc.

2.

Toll-like receptors in tumor immunotherapy.

Paulos CM, Kaiser A, Wrzesinski C, Hinrichs CS, Cassard L, Boni A, Muranski P, Sanchez-Perez L, Palmer DC, Yu Z, Antony PA, Gattinoni L, Rosenberg SA, Restifo NP.

Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5280-9. Review.

3.

Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccination.

Salem ML, Cole DJ.

Cancer Immunol Immunother. 2010 Mar;59(3):341-53. doi: 10.1007/s00262-009-0792-6. Epub 2009 Nov 18. Review.

4.

Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?

Muranski P, Boni A, Wrzesinski C, Citrin DE, Rosenberg SA, Childs R, Restifo NP.

Nat Clin Pract Oncol. 2006 Dec;3(12):668-81. Review.

5.

Adoptive immunotherapy for cancer: building on success.

Gattinoni L, Powell DJ Jr, Rosenberg SA, Restifo NP.

Nat Rev Immunol. 2006 May;6(5):383-93. Review.

6.
7.

Adoptive immunotherapy: good habits instilled at youth have long-term benefits.

Paulos CM, Suhoski MM, Plesa G, Jiang T, Basu S, Golovina TN, Jiang S, Aqui NA, Powell DJ Jr, Levine BL, Carroll RG, Riley JL, June CH.

Immunol Res. 2008;42(1-3):182-96. doi: 10.1007/s12026-008-8070-9. Review.

8.

Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy.

Klebanoff CA, Khong HT, Antony PA, Palmer DC, Restifo NP.

Trends Immunol. 2005 Feb;26(2):111-7. Review. No abstract available. Erratum in: Trends Immunol. 2005 Jun;26(6):298.

9.

Harnessing the Microbiome to Enhance Cancer Immunotherapy.

Nelson MH, Diven MA, Huff LW, Paulos CM.

J Immunol Res. 2015;2015:368736. doi: 10.1155/2015/368736. Epub 2015 May 25. Review.

10.

Technical Considerations for the Generation of Adoptively Transferred T Cells in Cancer Immunotherapy.

Visioni A, Skitzki J.

Cancers (Basel). 2016 Sep 20;8(9). pii: E86. doi: 10.3390/cancers8090086. Review.

Supplemental Content

Support Center